Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

Market Report, "Infectitious Diarrhea - Pipeline Review, H2 2013", published


Print article Print article
2013-12-19 03:06:07 - Recently published research from Global Markets Direct, "Infectitious Diarrhea - Pipeline Review, H2 2013", is now available at Fast Market Research

Global Markets Direct's, 'Infectitious Diarrhea - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Infectitious Diarrhea, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Infectitious Diarrhea. Infectitious Diarrhea - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Full Report Details at
- www.fastmr.com/prod/755171_infectitious_diarrhea_pipeline_review ..

Note*: Certain sections in the report may be removed or altered based on the availability and

relevance of data for the indicated disease.

Scope

* A snapshot of the global therapeutic scenario for Infectitious Diarrhea.
* A review of the Infectitious Diarrhea products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Infectitious Diarrhea pipeline on the basis of route of administration and molecule type.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to Get this Report

* Identify and understand important and diverse types of therapeutics under development for Infectitious Diarrhea.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Infectitious Diarrhea pipeline depth and focus of Indication therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Companies Mentioned in this Report: Actelion Ltd, Cubist Pharmaceuticals, Inc., Napo Pharmaceuticals, Inc., TheraCarb Inc.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Infectitious Diarrhea Overview
Therapeutics Development
An Overview of Pipeline Products for Infectitious Diarrhea
Infectitious Diarrhea Therapeutics under Development by Companies
Infectitious Diarrhea Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Infectitious Diarrhea Therapeutics - Products under Development by Companies
Infectitious Diarrhea Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Infectitious Diarrhea Therapeutics Development
Actelion Ltd
Cubist Pharmaceuticals, Inc.
Napo Pharmaceuticals, Inc.
TheraCarb Inc.
Infectitious Diarrhea - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
surotomycin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
crofelemer - Drug Profile
Product Description
Mechanism of Action
R&D Progress
cadazolid - Drug Profile
Product Description
Mechanism of Action
R&D Progress
MGB-BP-3 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Drug For Clostridium Difficile Associated Diarrhea - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PZ-7475 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
AKT-10081 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Serum Amyloid A Protein - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Enterotoxigenic Escherichia coli Vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Vaccine For Diarrhea - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Infectitious Diarrhea Therapeutics - Drug Profile Updates
Infectitious Diarrhea Therapeutics - Dormant Products
Infectitious Diarrhea - Product Development Milestones
Featured News & Press Releases
May 28, 2013: Antidiarrheal drug candidate moves to next phase of clinical study
Dec 21, 2012: Actelion's Cadazolid To Move Into Phase III Clinical Development In Patients With Clostridium Difficile Associated Diarrhea
Sep 06, 2012: Cubist Pharma To Feature Antibiotic Drug Candidate CB-315 At ICAAC 2012
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products Under Development for Infectitious Diarrhea, H2 2013
Products under Development for Infectitious Diarrhea - Comparative Analysis, H2 2013
Number of Products under Development by Companies, H2 2013
Number of Products under Investigation by Universities/Institutes, H2 2013
Comparative Analysis by Late Stage Development, H2 2013
Comparative Analysis by Mid Clinical Stage Development, H2 2013

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=755171&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser